Anti-Human CD45 Purified

Also known as: LCA

Clone: CD45-2B11

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-9457

Cat. No. Size
14-9457-80 25 ug
14-9457-82 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD45 Purified.

Immunohistochemistry on formalin-fixed paraffin embedded human pancreas, using 10 ug/mL of Mouse...View More

  • Data for Anti-Human CD45 Purified.
Description

Description: The CD45-2B11 monoclonal antibody reacts with human CD45, also known as Leukocyte Common Antigen (LCA). CD45 is expressed by all hematopoietic cells excluding circulating erythrocytes and platelets. The cytoplasmic portion of CD45 has tyrosine phosphatase enzymatic activity and plays an important role in lymphocyte proliferation and differentiation. The 2B11 antibody is useful for recognition of normal and neoplastic lymphoid cells.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate Purified
Reported Applications Flow Cytometric Analysis, Immunohistochemical Staining of Formalin-Fixed Paraffin Embedded Tissue Sections, Immunocytochemistry, Western Blotting
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
13-9457 Anti-Human CD45 Biotin IHC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
00-4954 20X TBS Wash Buffer for IHC/ICC ICC, IHC GPR
14-4714 Mouse IgG1 K Isotype Control Purified FC, ICC, IHC, IP, WB RUO
00-4956 IHC Antigen Retrieval Solution – High pH (10X) IHC GPR
References

References: Khalidi HS, Singleton TP, Weiss SW. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.Mod Pathol. 1997 May;10(5):438-42.

Warnke RA, Gatter KC, Falini B, Hildreth P, Woolston RE, Pulford K, Cordell JL, Cohen B, De Wolf-Peeters C, Mason DY. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. The New England Journal of Medicine. 1983, 309(21):1275-81.